Intensity Therapeutics, Inc.
General ticker "INTS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.6M (TTM average)
Intensity Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -26.3%.
Estimated limits based on current volatility of 4.5%: low 3.96$, high 4.33$
Factors to consider:
- Total employees count: 16 (-5.9%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Product development failure, Capital raising failure, Market competition
- Current price 15.6% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.74$, 15.77$]
- 2026-12-31 to 2027-12-31 estimated range: [4.01$, 13.34$]
Financial Metrics affecting the INTS estimates:
- Negative: with PPE of -0.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.83 <= 0.28
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of -15.99 <= 0
- Positive: Investing cash flow per share per price, % of 0 > -0.64
- Negative: negative Industry operating cash flow (median)
Short-term INTS quotes
Long-term INTS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $8.32MM | $16.59MM | $11.97MM |
| Operating Income | $-8.32MM | $-16.59MM | $-11.97MM |
| Non-Operating Income | $-2.22MM | $0.31MM | $0.37MM |
| Interest Expense | $0.30MM | $0.00MM | $0.00MM |
| R&D Expense | $4.79MM | $10.50MM | $6.79MM |
| Income(Loss) | $-10.54MM | $-16.27MM | $-11.61MM |
| Net Income(Loss)* | $-10.54MM | $-16.27MM | $-11.61MM |
| Stockholders Equity | $13.16MM | $2.92MM | $11.88MM |
| Assets | $17.30MM | $4.78MM | $14.10MM |
| Operating Cash Flow | $-7.21MM | $-15.22MM | $-9.23MM |
| Investing Cash Flow | $-6.02MM | $6.35MM | $0.00MM |
| Financing Cash Flow | $20.47MM | $2.90MM | $18.56MM |
| Earnings Per Share** | $-34.42 | $-29.25 | $-0.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.